糖尿病影响415万人在全世界，这个数字将增加到642万，到2030年。 这些大约27％的患者将有迹象的糖尿病视网膜病变，以及这些大约1/3将受到视觉障碍，如果不及时治疗。 大多数人与糖尿病有的时候，会有某种形式的糖尿病的眼睛变化。
Diabetic eye disease or otherwise known as Diabetic retinopathy may be in the form of mild ,moderate severe non proliferative disease or proliferative disease and/ or with diabetic macular oedema (fluid in the macular). These may be picked up by diabetic retinopathy screening programmes – of which patients attend annual screening when they have been diagnosed with diabetes. Moderate / severe or proliferative diseases and / or diabetic macular oedema findings will be referred further on to the hospital eye services.
有治疗方法可用于增殖阶段的糖尿病视网膜病变，即激光和/或antivegf注射。 临床试验也显示出卓越的回应，以处理与antivegf或眼睛的注射。 具有系统重要性的良好糖尿病/高血压和胆固醇控制可能有助于长期控制糖尿病的眼睛疾病。
重要的是糖尿病患者得到他们的眼睛筛选。
Ms Sharon Heng is a consultant ophthalmic surgeon from Moorfields Eye Surgeon and a medical retina and cataract specialist. she leads the medical retina digital clinic within the medical retina service in Moorfields Eye Hospital and is the lead for diabetic retinopathy screening in Ealing , Northwest London diabetic retinopathy screening programme. She was involved in developing teaching and training courses
对于糖尿病眼于眼科医生在中国。 Ms衡是现在接受患者进她的私人做法在摩菲私人的。
